Mycophenolate mofetil - as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience

Journal of Clinical Neuroscience

Volumn 14, Issue 3, 2007, Pages 278-281

  Prakash, K M ^a   Ratnagopal, P ^a   Puvanendran, K ^a   Lo, Y L ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Myasthenia gravis; Mycophenolate mofetil

Indexed keywords

AZATHIOPRINE; CHOLINERGIC RECEPTOR ANTIBODY; EDROPHONIUM CHLORIDE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PYRIDOSTIGMINE; STEROID;

ADD ON THERAPY; ADJUVANT THERAPY; ADULT; AGED; ANAMNESIS; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DOSAGE SCHEDULE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; MALE; MOON FACE; MYASTHENIA GRAVIS; NERVE STIMULATION; OSTEOPENIA; PLASMAPHERESIS; PRIORITY JOURNAL; THYMECTOMY;

ADULT; AGED; CHOLINESTERASE INHIBITORS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; MYCOPHENOLIC ACID; PREDNISOLONE; PYRIDOSTIGMINE BROMIDE; SEVERITY OF ILLNESS INDEX; SINGAPORE;

EID: 33846365961     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2005.12.008     Document Type: Article

References (17)

1. Hohlfeld R., Michels M., Heininger K., Besinger U., and Toyka K.V. Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis. Neurology 38 (1988) 258-261
2. Ciafaloni E., Nikhar N.K., Massey J.M., and Sanders D.B. Retrospective analysis of the use of cyclosporine in myasthenia gravis. Neurology 55 (2000) 448-450
3. Allison A.C., and Eugui E.M. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 10 (1996) 77-84
4. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. Lancet 345 (1995) 1321-1325
5. Sollinger HW for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60 (1995) 225-232
6. Behrend M. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation. Clin Nephrol 45 (1996) 336-341
7. Allison A.C., and Eugui E.M. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation. Transplant Proc 26 (1994) 3205-3210
8. Hauser R.A., Malek A.R., and Rosen R. Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil. Neurology 51 (1998) 912-913
9. Ciafaloni E., Massey J.M., Tucker-Lipscomb B., and Sanders D.B. Mycophenolate mofetil for myasthenia gravis: an open-label pilot study. Neurology 56 (2001) 97-99
10. Meriggioli M.N., Rowin J., Richman J.G., and Leurgans S. Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study. Ann NY Acad Sci 998 (2003) 494-499
11. Chaudhry V., Cornblath D.R., Griffin J.W., O'Brien R., and Drachman D.B. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 56 (2001) 94-96
12. Vernino S., Salomao D.R., Habermann T.M., and O'Neill B.P. Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil. Neurology 65 (2005) 639-641
13. Levin N., Mali A., and Karussis D. Severe skin reaction related to mycophenolate mofetil for myasthenia gravis. Clin Neuropharmacol 28 (2005) 152-153
14. Haberal M., Karakayali H., Emiroglu R., Basaran O., Moray G., and Bilgin N. Malignant tumors after organ transplantation. Artif Organs 26 (2002) 778-781
15. Schneider C., Gold R., Reiners K., and Toyka K.V. Mycophenolate mofetil in the therapy of severe myasthenia gravis. Eur Neurol 46 (2001) 79-82
16. Danovitch G.M. Mycophenolate mofetil in renal transplant: results from the U.S. randomized trials. Kidney Int 52 (1995) S93-S96
17. Sollinger H.W. Mycophenolate mofetil. Kidney Int 52 (1995) S14-S17